AQST icon

Aquestive Therapeutics
AQST

Overview Fund Activity

40 hedge funds and large institutions have $61M invested in Aquestive Therapeutics in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-9
Holders Change %
-18.37%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
5
Reduced
15
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OM
Opaleye Management
Massachusetts
+$2.48M
2
Millennium Management
Millennium Management
New York
+$1.12M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$361K
4
WS
Wedbush Securities
California
+$297K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$249K

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$2.19M
2
BlackRock
BlackRock
New York
-$1.76M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$342K
4
State Street
State Street
Massachusetts
-$338K
5
Goldman Sachs
Goldman Sachs
New York
-$278K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIG
51
American International Group
New York
– -$50K -7,211 Closed
Victory Capital Management
52
Victory Capital Management
Texas
– -$35K -5,000 Closed
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
– -$31K -4,500 Closed
SO
54
STRS Ohio
Ohio
– -$10K -1,500 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– -$7K -951 Closed
AIP
56
Ameritas Investment Partners
Nebraska
– -$3K -400 Closed
1 2
3